En Sudáfrica, uno de cada 5 adultos está infectado con el virus del sida (VIH). Actualmente son ya más de 4 millones de personas las que sufren allí la enfermedad. El Gobierno de Sudáfrica ha aprobado leyes que abaratan y hacen accesibles los fármacos esenciales para el tratamiento, pero 39 empresas farmacéuticas multinacionales, que poseen las patentes de dichos fármacos, han iniciado un juicio en contra de dichas leyes. El juicio se celebrará el próximo 18 de abril.

MÉDICOS SIN FRONTERAS pide firmas para exigir a las 39 empresas farmacéuticas que retiren su demanda. POR FAVOR, AYÚDANOS A LOGRARLO.

SI ESTÁS DE ACUERDO, ENTRA EN NUESTRA PÁGINA WEB: <http://www.msf.es>  Y FIRMA LA PETICIÓN DE PROTESTA en <http://www.msf.es/4_1.asp>. COPIA LUEGO ESTE MENSAJE OMITIENDO LA DIRECCIÓN DE QUIEN TE LO ENVÍA Y HAZLO LLEGAR AL MÁXIMO DE PERSONAS POSIBLE.

==================================

Sign the Drop the Case petition. MSF will send your signature* to the 39 pharmaceutical companies and to governments to send a clear message that protecting lives should come before protecting patents.

*Only your name and country of residence will be sent to companies and governments. MSF will not release your email address publicly. The 39 pharmaceutical companies in the South African court case webplaced:

March 9, 2001

A complete list of the 39 pharmaceutical companies suing the South African government to prevent the distribution of essential medications under South African law.

- The Pharmaceutical Manufacturers' Association of South Africa

- Alcon Laboratories (S.A.) (Proprietary) Limited

- Bayer (Proprietary) Limited

- Bristol-Myers Squibb (Proprietary) Limited

- Byk Madaus (Proprietary) Limited

- Eli Lilly (South Africa) (Proprietary) Limited

- Glaxo Wellcome (South Africa) (Proprietary) Limited

- Hoechst Marion Roussel Limited

- Ingelheim Pharmaceuticals (Proprietary) Limited

- Janssen-Cilag Pharmaceutica (Proprietary) Limited

- Knoll Pharmaceuticals South Africa (Proprietary) Limited

- Lundbeck South Africa (Proprietary) Limited

- Merck (Proprietary) Limited

- MSD (Proprietary) Limited

- Novartis South Africa (Proprietary) Limited

- Novo Nordisk (Proprietary) Limited

- & Upjohn (Proprietary) Limited

- Rhone-Poulenc Rorer South Africa (Proprietary) Limited

- Roche Products (Proprietary) Limited

- Schering (Proprietary) Limited

- Schering-Plough (Proprietary) Limited

- S.A. Scientific Pharmaceuticals (Proprietary) Limited

- SmithKline Beecham Pharmaceuticals (Proprietary) Limited Universal

- Pharmaceuticals (Proprietary) Limited

- Wyeth (Proprietary) Limited

- Xixia Pharmaceuticals (Proprietary) Limited

- Zeneca South Africa (Proprietary) Limited

- Bayer AG

- Boehringer-Ingelheim International GmbH

- Boehringer-Ingelheim KG

- Bristol-Myers Squibb Company

- Byk Gulden Lomberg Chemische Fabrik GmbH

- Dr. Karl Thomae GmbH

- Eli Lilly and Company

- F. Hoffman-La Roche AG

- Merck KGaA

- & Co., Inc.

- Rhone-Poulenc Rorer S.A.